Literature DB >> 30693642

Occurrence of high-grade glioma in Noonan syndrome: Report of two cases.

Moatasem El-Ayadi1,2,3,4, Marc Ansari1,2, Caspar D Kühnöl5, Anne Bendel6, Dominik Sturm7,8, Torsten Pietsch9, Christof M Kramm10, André O von Bueren1,2.   

Abstract

Noonan syndrome (NS) is an autosomal dominant disorder commonly caused by PTPN11 germline mutations. Patients are characterized by short stature, congenital heart defects, facial dysmorphism, and increased risk of malignancies including brain tumors. Commonly associated brain tumors are dysembryoplastic neuroepithelial tumor and low-grade glioma. We report two cases of anaplastic astrocytoma with PTPN11-related NS. We conducted a systematic search of medical databases looking for other reported cases of high-grade glioma associated with NS and identified 24 cases of brain tumors, all of which were low-grade glial or glioneuronal tumors except for one case of medulloblastoma.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Noonan syndrome; PTPN11 mutations; RASopathy; brain tumorzzm321990; high-grade glioma

Mesh:

Substances:

Year:  2019        PMID: 30693642     DOI: 10.1002/pbc.27625

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  SHP2 mutations induce precocious gliogenesis of Noonan syndrome-derived iPSCs during neural development in vitro.

Authors:  Younghee Ju; Jun Sung Park; Daejeong Kim; Bumsoo Kim; Jeong Ho Lee; Yoonkey Nam; Han-Wook Yoo; Beom Hee Lee; Yong-Mahn Han
Journal:  Stem Cell Res Ther       Date:  2020-06-03       Impact factor: 6.832

2.  A First Case Report of Subependymoma in PTPN11 Mutation-Associated Noonan Syndrome.

Authors:  Boonchai Boonyawat; Mongkon Charoenpitakchai; Piradee Suwanpakdee
Journal:  Case Rep Neurol Med       Date:  2019-09-16

Review 3.  Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.

Authors:  Stefano Stagi; Vittorio Ferrari; Marta Ferrari; Manuela Priolo; Marco Tartaglia
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-18       Impact factor: 6.055

4.  Effect of Growth Hormone Therapy in Patients with Noonan Syndrome: A Retrospective Study.

Authors:  Louise Jayne Apperley; Renuka Ramakrishnan; Poonam Dharmaraj; Urmi Das; Mohammed Didi; Jo Blair; Senthil Senniappan
Journal:  Int J Endocrinol Metab       Date:  2020-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.